Scholarlink

Background <p><i>Parathyridaria percutanea</i> is a rare melanized fungus causing subcutaneous phaeohyphomycosis, previously reported only in renal transplant recipients. We report the first fatal case in a liver transplant (LT) recipient.</p> Case presentation <p>A 58-year-old Somali woman developed a right foot fungating mass 10 months post-LT during intensive immunosuppression for multiple episodes of T-cell-mediated and antibody-mediated rejection (high-dose corticosteroids, antithymocyte globulin, plasmapheresis). Cultures of drainage and subsequent operative deep-tissue cultures grew <i>Enterococcus faecalis</i> and <i>Finegoldia</i> species, together with a non-sporulating filamentous mould. Despite empiric antifungals, infection progressed proximally in sporotrichoid pattern. Molecular identification using DNA sequencing of ITS and D1/D2 regions identified <i>P. percutanea</i> after three weeks. Treatment with liposomal amphotericin B/voriconazole was complicated by acute kidney injury requiring amphotericin discontinuation. Despite antifungal therapy and surgical debridement, the patient developed progressive encephalopathy and allograft dysfunction, resulting in death.</p> Conclusions <p>This first fatal <i>P. percutanea</i> infection following LT highlights the importance of early molecular diagnostics for non-sporulating filamentous fungi in immunocompromised hosts and management challenges under intensive immunosuppression.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Invasive phaeohyphomycosis due to Parathyridaria percutanea in a liver transplant recipient

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月22日

查看全文
  • Ayato Obana,
  • Miho Akabane,
  • Yusuke Ohashi,
  • Neelesh Bagrodia,
  • Austin Schenk,
  • Sylvester Black,
  • Kenneth Washburn,
  • Nathan P. Wiederhold,
  • Connie F. Cañete-Gibas,
  • Jude Meniru,
  • Courtney Nichols,
  • Sajed Sarwar,
  • Nicholas Marschalk

摘要

Background

Parathyridaria percutanea is a rare melanized fungus causing subcutaneous phaeohyphomycosis, previously reported only in renal transplant recipients. We report the first fatal case in a liver transplant (LT) recipient.

Case presentation

A 58-year-old Somali woman developed a right foot fungating mass 10 months post-LT during intensive immunosuppression for multiple episodes of T-cell-mediated and antibody-mediated rejection (high-dose corticosteroids, antithymocyte globulin, plasmapheresis). Cultures of drainage and subsequent operative deep-tissue cultures grew Enterococcus faecalis and Finegoldia species, together with a non-sporulating filamentous mould. Despite empiric antifungals, infection progressed proximally in sporotrichoid pattern. Molecular identification using DNA sequencing of ITS and D1/D2 regions identified P. percutanea after three weeks. Treatment with liposomal amphotericin B/voriconazole was complicated by acute kidney injury requiring amphotericin discontinuation. Despite antifungal therapy and surgical debridement, the patient developed progressive encephalopathy and allograft dysfunction, resulting in death.

Conclusions

This first fatal P. percutanea infection following LT highlights the importance of early molecular diagnostics for non-sporulating filamentous fungi in immunocompromised hosts and management challenges under intensive immunosuppression.

Clinical trial number

Not applicable.